EU Article 13 of the EU Medical Device Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR) include a new requirement to appoint an importer if your company has no legal entity in Europe. Your importer is responsible for verifying your compliance with the MDR and IVDR as your authorized representative and has their respective responsibilities.
Differences Between an EU Importer and an Authorized Representative
This may be a little confusing because you may already have an EU Authorized Representative (EC REP) and you may be wondering what distinguishes the role of each party. That’s an excellent question. Let’s take a quick look at the responsibilities of your EU Authorized Representative vs those of your importer.
NOTE: We make reference to Chapter 2, Articles 11 and 13 of the MDR below. You can refer to the exact language specified in those articles here.
Your EU Authorized Representative (EC REP) and EU Importer both Must do the Following:

MedEnvoy can act as your independent EU importer and EC REP. Request a proposal.
Additional Responsibilities of Your EU Importer
Your Authorized Representative (EC REP) reviews and confirms that the device is CE Marked, confirms that all information is complete, and maintains access to client technical documentation. Even after this is complete, the EC REP remains available to support the client in vigilance related matters. In addition to the shared responsibilities noted in the table above, outlined in MDR Article 13, your EU Importer is also responsible for:
- Verifying that labeling and accompanying Instructions for Use are correct/present. See MDR Article 13(2c)
- Verifying that the manufacturer, EU Importer and EU Authorized Representative have been identified. See MDR Article 13(2b)
- Verifying that the device storage and transportation conditions don’t jeopardize compliance with General Safety and Performance Requirements (GSPR). See MDR Article 13(5)
- Maintaining a register of complaints, non-conforming devices, recalls and withdrawals – See MDR Article 13(6)
- Ensuring that the manufacturer has assigned UDI to devices – See MDR Article 13(2d)
Differences in Liability Exposure
One of key differences between the EU Authorized Representative vs the EU Importer has to do with exposure. Your contract with your authorized representative (and the amount they charge) takes into account the fact that they can be held legally liable for your defective devices sold in Europe per MDR Article 11(5). Similarly, your Importer has significant exposure in that they can be held financially liable for your non-compliance with the MDR. The difference here is that the importer is responsible for “placing the device on the market.”
Furthermore, EU Regulation 2019/1020 takes effect in 2021 and supplements the MDR and IVDR. Article 15 states the following:
Recovery of Costs by Market Surveillance Authorities
- Member States may authorize their market surveillance authorities to reclaim from the relevant economic operator the totality of the costs of their activities with respect to instances of non-compliance.
- The costs referred to in paragraph 1 of this Article may include the costs of carrying out testing, the costs of taking measures in accordance with Article 28(1) and (2), the costs of storage and the costs of activities relating to products that are found to be non-compliant and are subject to corrective action prior to their release for free circulation or their placing on the market.
MedEnvoy as Your Regulatory Importer
While many non-EU manufacturers opt to maintain separate importers and authorized representatives, others have chosen to have a single entity take on both roles. MedEnvoy’s regulatory importer service allows you to exercise more control over compliance in your distribution chain without disrupting the way you import your devices today.